3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model

Journal of Hepatology

Volumn 63, Issue 3, 2015, Pages 689-696

  Farrar, Christian T ^a   Deperalta, Danielle K ^b   Day, Helen ^a   Rietz, Tyson A ^a   Wei, Lan ^b   Lauwers, Gregory Y ^a   Keil, Boris ^a   Subramaniam, Arun ^c   Sinskey, Anthony J ^d   Tanabe, Kenneth K ^b   Fuchs, Bryan C ^b   Caravan, Peter ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SANOFI   (France)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Bile duct ligation (BDL); EP 3533; Liver fibrosis; Molecular imaging; MRI; Non invasive; Type I collagen

Indexed keywords

COLLAGEN TYPE 1; EP 3533; HYDROXYPROLINE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; RAPAMYCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; DISEASE COURSE; LIVER FIBROSIS; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; RECEIVER OPERATING CHARACTERISTIC; THREE DIMENSIONAL IMAGING; TREATMENT RESPONSE; ANIMAL; BILE DUCT; DISEASE MODEL; ELASTOGRAPHY; LIGATION; LIVER CIRRHOSIS, EXPERIMENTAL; PATHOLOGY; PROCEDURES;

ANIMALS; BILE DUCTS; DISEASE MODELS, ANIMAL; ELASTICITY IMAGING TECHNIQUES; LIGATION; LIVER CIRRHOSIS, EXPERIMENTAL; MAGNETIC RESONANCE IMAGING; MALE; RATS; ROC CURVE; SIROLIMUS;

EID: 84939258042     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.04.029     Document Type: Article

References (42)

1. R. Williams Global challenges in liver disease Hepatology 44 2006 521 526
2. S.L. Friedman Mechanisms of hepatic fibrogenesis Gastroenterology 134 2008 1655 1669
3. J.P. Iredale Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ J Clin Invest 117 2007 539 548
4. S.L. Friedman, and M.B. Bansal Reversal of hepatic fibrosis - Fact or fantasy? Hepatology 43 2006 S82 S88
5. J.A. Fallowfield, T.J. Kendall, and J.P. Iredale Reversal of fibrosis: no longer a pipe dream? Clin Liver Dis 10 2006 481 497 viii
6. D. Schuppan, and N.H. Afdhal Liver cirrhosis Lancet 371 2008 838 851
7. S.L. Friedman Evolving challenges in hepatic fibrosis Nat Rev Gastroenterol Hepatol 7 2010 425 436
8. R.P. Myers, A. Fong, and A.A. Shaheen Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies Liver Int 28 2008 705 712
9. B. Terjung, I. Lemnitzer, F.L. Dumoulin, W. Effenberger, H.H. Brackmann, T. Sauerbruch, and et al. Bleeding complications after percutaneous liver biopsy. An analysis of risk factors Digestion 67 2003 138 145
10. Y. Popov, and D. Schuppan Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies Hepatology 50 2009 1294 1306
11. P. Caravan, B. Das, S. Dumas, F.H. Epstein, P.A. Helm, V. Jacques, and et al. Collagen-targeted MRI contrast agent for molecular imaging of fibrosis Angew Chem Int Ed Engl 46 2007 8171 8173
12. M. Polasek, B.C. Fuchs, R. Uppal, D.T. Schuhle, J.K. Alford, G.S. Loving, and et al. Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models J Hepatol 57 2012 549 555
13. P. Caravan, Y. Yang, R. Zachariah, A. Schmitt, M. Mino-Kenudson, H.H. Chen, and et al. Molecular magnetic resonance imaging of pulmonary fibrosis in mice Am J Respir Cell Mol Biol 49 2013 1120 1126
14. B.C. Fuchs, H. Wang, Y. Yang, L. Wei, M. Polasek, D.T. Schuhle, and et al. Molecular MRI of collagen to diagnose and stage liver fibrosis J Hepatol 59 2013 992 998
15. P.A. Helm, P. Caravan, B.A. French, V. Jacques, L. Shen, Y. Xu, and et al. Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent Radiology 247 2008 788 796
16. E. Patsenker, V. Schneider, M. Ledermann, H. Saegesser, C. Dorn, C. Hellerbrand, and et al. Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis J Hepatol 55 2011 388 398
17. M. Neef, M. Ledermann, H. Saegesser, V. Schneider, and J. Reichen Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis J Hepatol 45 2006 786 796
18. K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. De Groote, F. Gudat, and et al. Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
19. P.R. Hutson, M.E. Crawford, and R.L. Sorkness Liquid chromatographic determination of hydroxyproline in tissue samples J Chromatogr B Analyt Technol Biomed Life Sci 791 2003 427 430
20. V. Calvaruso, A.K. Burroughs, R. Standish, P. Manousou, F. Grillo, G. Leandro, and et al. Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient Hepatology 49 2009 1236 1244
21. K.R. Bridle, C. Popa, M.L. Morgan, A.L. Sobbe, A.D. Clouston, L.M. Fletcher, and et al. Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways Liver Transpl 15 2009 1315 1324
22. E. Biecker, A. De Gottardi, M. Neef, M. Unternahrer, V. Schneider, M. Ledermann, and et al. Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms J Pharmacol Exp Ther 313 2005 952 961
23. M. Yin, J.A. Talwalkar, K.J. Glaser, A. Manduca, R.C. Grimm, P.J. Rossman, and et al. Assessment of hepatic fibrosis with magnetic resonance elastography Clin Gastroenterol Hepatol 5 2007 e1202
24. L. Sandrin, B. Fourquet, J.M. Hasquenoph, S. Yon, C. Fournier, F. Mal, and et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis Ultrasound Med Biol 29 2003 1705 1713
25. E.A. Osborn, and F.A. Jaffer The year in molecular imaging JACC Cardiovasc Imaging 5 2012 317 328
26. Y. Inagaki, R. Higashiyama, and K. Higashi Novel anti-fibrotic modalities for liver fibrosis: molecular targeting and regenerative medicine in fibrosis therapy J Gastroenterol Hepatol 27 2012 85 88
27. T. Kisseleva, and D.A. Brenner Anti-fibrogenic strategies and the regression of fibrosis Best Pract Res Clin Gastroenterol 25 2011 305 317
28. D.C. Rockey Current and future anti-fibrotic therapies for chronic liver disease Clin Liver Dis 12 2008 939 962 xi
29. D. Schuppan, and M. Pinzani Anti-fibrotic therapy: lost in translation? J Hepatol 56 2012 S66 S74
30. S.L. Friedman, D. Sheppard, J.S. Duffield, and S. Violette Therapy for fibrotic diseases: nearing the starting line Sci Transl Med 5 2013 167sr161
31. S.L. Friedman Focus J Hepatol 57 2012 481 483
32. A. Regev, M. Berho, L.J. Jeffers, C. Milikowski, E.G. Molina, N.T. Pyrsopoulos, and et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection Am J Gastroenterol 97 2002 2614 2618
33. O. Rouviere, M. Yin, M.A. Dresner, P.J. Rossman, L.J. Burgart, J.L. Fidler, and et al. MR elastography of the liver: preliminary results Radiology 240 2006 440 448
34. L. Huwart, C. Sempoux, N. Salameh, J. Jamart, L. Annet, R. Sinkus, and et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index Radiology 245 2007 458 466
35. R. Loomba, T. Wolfson, B. Ang, J. Hooker, C. Behling, M. Peterson, and et al. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study Hepatology 60 2014 1920 1928
36. U. Arena, F. Vizzutti, G. Corti, S. Ambu, C. Stasi, S. Bresci, and et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography Hepatology 47 2008 380 384
37. J. Chen, J.A. Talwalkar, M. Yin, K.J. Glaser, S.O. Sanderson, and R.L. Ehman Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography Radiology 259 2011 749 756
38. B. Taouli, R.L. Ehman, and S.B. Reeder Advanced MRI methods for assessment of chronic liver disease AJR Am J Roentgenol 193 2009 14 27
39. S.K. Venkatesh, M. Yin, and R.L. Ehman Magnetic resonance elastography of liver: technique, analysis, and clinical applications J Magn Reson Imaging 37 2013 544 555
40. R. Banerjee, M. Pavlides, E.M. Tunnicliffe, S.K. Piechnik, N. Sarania, R. Philips, and et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease J Hepatol 60 2014 69 77
41. S.B. Reeder, I. Cruite, G. Hamilton, and C.B. Sirlin Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy J Magn Reson Imaging 34 2011 729 749
42. J.A. Talwalkar, M. Yin, J.L. Fidler, S.O. Sanderson, P.S. Kamath, and R.L. Ehman Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications Hepatology 47 2008 332 342